Bd launches industry-first bioabsorbable mesh designed for umbilical hernia repair

Phasix™ st umbilical hernia patch leverages same surgical technique as permanent mesh procedures  franklin lakes, n.j. , april 23, 2025 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced 510(k) clearance from the u.s. food and drug administration (fda) and the commercial launch of phasix™ st umbilical hernia patch, the first and only fully absorbable hernia patch on the market designed specifically for umbilical hernias.
BDX Ratings Summary
BDX Quant Ranking